https://stock.noler.com/us/stock/us-china-biomedical-technology-inc https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accounts-notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accounts-payable https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accrued-payroll-taxes-current-and-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accrued-salaries-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/accrued-salaries-current-and-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/additional-paid-in-capital https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/adjustment-for-amortization https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/allowance-for-loan-and-lease-losses-write-offs https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/bank-overdrafts https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/basic-shares https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/business-acquisition-purchase-price-allocation-liabilities-assumed https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/capitalized-computer-software-additions https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/capitalized-computer-software-gross https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/capitalized-computer-software-net https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/capitalized-software-development-costs-for-software-sold-to-customers https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/cash https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/cash-and-equivalents https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/cash-change https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/cash-flow-breakdown https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/common-stock-value https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/current-assets https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/current-liabilities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/debt-convertible-effective-interest-rate https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deposits-assets-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/due-to-officers-or-stockholders-current-and-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/due-to-related-parties-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/effective-tax-rate https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/eps-basic https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/fees-and-commissions https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/financial-services-costs https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/financing-cash-flow https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/form-d-stocks https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/general-and-administrative-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/income-tax https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/income-taxes-paid https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-book-overdrafts https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/insider-transactions-warrants https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/interest-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/interest-expense-other https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/interest-expense-related-party https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/interest-paid https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/interest-paid-net https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/investing-cash-flow https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/lease-and-rental-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/lease-cost https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/legal-fees https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/marketing-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/net-change-in-cash https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/net-income https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/notes-and-loans-payable-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-cash-flow https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-expenses https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-income https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-assets https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-liability https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-liability-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-payments-due https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/other-amortization-of-deferred-charges https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/other-expenses https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/other-noncash-income https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/paid-in-capital-other https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/payments-for-software https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/payments-to-fund-longterm-loans-to-related-parties https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/preferred-shares-facts https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/preferred-stock-value https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/prepaid-expense-current https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/prepaid-rent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/pretax-income https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-collection-of-advance-to-affiliate https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-contributions-from-affiliates https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/public-float https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/research-and-development https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/restricted-stock-shares-issued-net-of-shares-for-tax-withholdings https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/retained-earnings https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/revenue https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/shareholders-equity https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/shares-authorized https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/shares-issued https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/shares-issued-shares-share-based-compensation-gross https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-based-compensation https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-issued-shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/total-assets https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/total-liabilities https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/treasury-stock-shares https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/us-china-biomedical-technology-inc/weighted-average-number-of-share-outstanding-basic-and-diluted